Related Experiment Video

Updated: May 12, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set

Maja B Drakenberg Danese1, Christoffer P Vannas2, Henrik A Fagman3

  • 1Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Region Vastra Gotaland, Sweden.

Acta Oncologica (Stockholm, Sweden)
|May 11, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...